⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28115644 | 0.92 | EPHX2 (0.32) | — | |
| SCHEMBL12671592 | 0.82 | — | — | |
| SCHEMBL12738277 | 0.82 | — | — | |
| SCHEMBL28447382 | 0.82 | — | — | |
| SCHEMBL910819 | 0.82 | — | — | |
| SCHEMBL6575630 | 0.82 | — | — | |
| SCHEMBL13657837 | 0.80 | CA1 (0.36) | — | |
| SCHEMBL9466425 | 0.78 | AKR1B1 (0.54) | — | |
| SCHEMBL7285546 | 0.78 | LMNA (0.32) | — | |
| SCHEMBL7358884 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2497475-A1 | Treatment of laminitis with platelet aggregation inhibitors | Dussler, Sabine (DE) | 2012-09-12 | — | — | EP | disclosed |
| CN-1192019-C | Cyclic amine derivatives | SANKYO CO (JP) | 2005-03-09 | — | — | CN | disclosed |
| EP-0934928-B1 | CYCLIC AMINE DERIVATIVES | SANKYO CO (JP) | 2004-10-13 | — | — | EP | disclosed |
| CN-1107502-C | Preparation method for medicinal composition containing hydrogenated pyridine derivative as active components | SANKYO CO (JP) | 2003-05-07 | — | — | CN | disclosed |
| US-6087379-A | AN ANTICOAGULANT FOR THE TREATMENT AND PREVENTION OF DISEASES AS EMBOLISM, THROMBOSIS OR ARTERIOSCLEROSIS | SANKYO COMPANY, LIMITED (JP) | 2000-07-11 | — | — | US | disclosed |
| EP-0934928-A1 | CYCLIC AMINE DERIVATIVES | SANKYO COMPANY LIMITED (JP) | 1999-08-11 | — | — | EP | disclosed |
| CN-1217186-A | Preparation method for medicinal composition containing hydrogenated pyridine derivative as active components | SANKYO CO (JP) | 1999-05-26 | — | — | CN | disclosed |
| CN-1041730-C | Process for preparing hydrogenated pyridine derivatives | SANKYO CO (JP) | 1999-01-20 | — | — | CN | disclosed |
| US-5436242-A | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood platelet aggregation | SANKYO COMPANY, LIMITED (JP) | 1995-07-25 | — | — | US | disclosed |
| US-5288726-A | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation | UBE INDUSTRIES LIMITED (JP) | 1994-02-22 | — | — | US | disclosed |
| CN-1074446-A | Hydroxypyridine Derivatives | SANKYO CO (JP) | 1993-07-21 | — | — | CN | disclosed |
| EP-0542411-A2 | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation | Sankyo Company Limited (JP) | 1993-05-19 | — | — | EP | disclosed |